Showing results 1 to 20 of 424
next >
Issue Date | Title | Author(s) |
2021-01-28 | A cluster randomised trial of a Needs Assessment Tool for adult Cancer patients and their carers (NAT-C) in primary care: A feasibility study. | Clark, J; Amoakwa, E; Wright-Hughes, A; Blenkinsopp, J; Currow, DC; Meads, D; Farrin, A; Allgar, V; Macleod, U; Johnson, M |
2022-04 | A feasibility and acceptability pilot for the longitudinal measurement of inspiratory and expiratory pressures in people with advanced pancreatic cancer. | Allen, J; Dudgeon, D; Hunt, T; Currow, DC |
2022-10 | A Focus Group Study of Palliative Physician and Consultation-Liaison Psychiatrist Perceptions of Dealing with Depression in the Dying | Lee, W; DiGiacomo, M; Draper, B; Agar, MR; Currow, DC |
2020 | A perfect storm: fear of litigation for end of life care. | Mitchell, GK; Willmott, L; White, BP; Piper, D; Currow, DC; Yates, PM |
2021-01-28 | A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer | Currow, DC; Glare, P; Louw, S; Martin, P; Clark, K; Fazekas, B; Agar, MR |
2020-05 | A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids. | Currow, DC; Clark, K; Louw, S; Fazekas, B; Greene, A; Sanderson, CR |
2020-07-28 | A systematic review and meta-analysis of studies comparing burden from lung cancer and chronic obstructive pulmonary disease. | Luckett, T; San Martin, A; Currow, DC; Johnson, MJ; Barnes-Harris, MM; Phillips, JL |
2015-05-09 | Academic detailing of general practitioners by a respiratory physician for diagnosis and management of refractory breathlessness: A randomised pilot study Organization, structure and delivery of healthcare | Collier, A; Rowett, D; Allcroft, P; Greene, A; Currow, DC |
2014-01-01 | The active identification and management of chronic refractory breathlessness is a human right | Currow, DC; Abernethy, AP; Ko, DN |
2020-08-01 | Activities Forgone because of Chronic Breathlessness: A Cross-Sectional Population Prevalence Study | Kochovska, S; Chang, S; Morgan, DD; Ferreira, D; Sidhu, M; Saleh Moussa, R; Johnson, MJ; Ekström, M; Currow, DC |
2012-11-01 | Activity as a measure of symptom control | Currow, DC; Abernethy, AP; Johnson, MJ |
2016-05-01 | The Adaptation, Face, and Content Validation of a Needs Assessment Tool: Progressive Disease for People with Interstitial Lung Disease | Boland, JW; Reigada, C; Yorke, J; Hart, SP; Bajwah, S; Ross, J; Wells, A; Papadopoulos, A; Currow, DC; Grande, G; Macleod, U; Johnson, MJ |
2014-01-01 | Advancing research into symptoms of constipation at the end of life | Clark, K; Currow, DC |
2011-03-01 | Adverse events in hospice and palliative care: A pilot study to determine feasibility of collection and baseline rates | Currow, DC; Agar, MR; To, THM; Rowett, D; Greene, A; Abernethy, AP |
2019-04-01 | Agreement Between Breathlessness Severity and Unpleasantness in People With Chronic Breathlessness: A Longitudinal Clinical Study | Ekström, M; Williams, M; Johnson, MJ; Huang, C; Currow, DC |
2015-01-01 | Analysis of drug interactions at the end of life | Morgan, NA; Rowett, D; Currow, DC |
2014-01-01 | An analytical framework for delirium research in palliative care settings: Integrated epidemiologic, clinician-researcher, and knowledge user perspectives | Lawlor, PG; Davis, DHJ; Ansari, M; Hosie, A; Kanji, S; Momoli, F; Bush, SH; Watanabe, S; Currow, DC; Gagnon, B; Agar, M; Bruera, E; Meagher, DJ; De Rooij, SEJA; Adamis, D; Caraceni, A; Marchington, K; Stewart, DJ |
2012-01-01 | Analyzing phase III studies in hospice/palliative care. A solution that sits between intention-to-treat and per protocol analyses: The palliative-modified ITT analysis | Currow, DC; Plummer, JL; Kutner, JS; Samsa, GP; Abernethy, AP |
2014-01-01 | Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome | Currow, DC; Abernethy, AP |
2016-04-01 | Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials | Temel, JS; Abernethy, AP; Currow, DC; Friend, J; Duus, EM; Yan, Y; Fearon, KC |